These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34782275)

  • 1. Current possibilities and future perspectives for improving efficacy of allergen-specific sublingual immunotherapy.
    Sadeghi M; Keshavarz Shahbaz S; Dehnavi S; Koushki K; Sankian M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108350. PubMed ID: 34782275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Allergen-Presentation Platforms for Sublingual Immunotherapy.
    Moingeon P; Lombardi V; Baron-Bodo V; Mascarell L
    J Allergy Clin Immunol Pract; 2017; 5(1):23-31. PubMed ID: 28065340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.
    Moingeon P; Mascarell L
    Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanisms of sublingual immunotherapy.
    Jay DC; Nadeau KC
    Curr Allergy Asthma Rep; 2014 Nov; 14(11):473. PubMed ID: 25195100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvants and vector systems for allergy vaccines.
    Moingeon P; Lombardi V; Saint-Lu N; Tourdot S; Bodo V; Mascarell L
    Immunol Allergy Clin North Am; 2011 May; 31(2):407-19, xii. PubMed ID: 21530828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological mechanisms of sublingual immunotherapy.
    Allam JP; Novak N
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):564-9. PubMed ID: 25233080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE; Sandrini A; Anderson GP; Rolland JM
    Curr Med Chem; 2007; 14(21):2235-44. PubMed ID: 17896972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician.
    Moingeon P
    J Allergy Clin Immunol Pract; 2013; 1(3):228-41. PubMed ID: 24565479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DC-targeted gold nanoparticles as an efficient and biocompatible carrier for modulating allergic responses in sublingual immunotherapy.
    Sadeghi M; Koushki K; Mashayekhi K; Ayati SH; Keshavarz Shahbaz S; Moghadam M; Sankian M
    Int Immunopharmacol; 2020 Sep; 86():106690. PubMed ID: 32585607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single vs multiallergen sublingual immunotherapy in the polysensitized patient: a pilot study.
    Ortiz AS; McMains KC; Laury AM
    Int Forum Allergy Rhinol; 2018 Apr; 8(4):490-494. PubMed ID: 29377605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.
    Lawrence MG; Steinke JW; Borish L
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):138-42. PubMed ID: 27499541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvants for allergy vaccines.
    Moingeon P
    Hum Vaccin Immunother; 2012 Oct; 8(10):1492-8. PubMed ID: 23095872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual Immunotherapy with Sal k1 Expressing Lactococcus lactis Down-regulates Th2 Immune Responses in Balb/c Mice.
    Ghasemi Z; Varasteh AR; Moghadam M; Jalali SA; Anissian A; Sankian M
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):281-290. PubMed ID: 29908546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):71-86. PubMed ID: 26617228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive sublingual immunotherapy in preschool children: first evidence for safety and pro-tolerogenic effects.
    Szépfalusi Z; Bannert C; Ronceray L; Mayer E; Hassler M; Wissmann E; Dehlink E; Gruber S; Graf A; Lupinek C; Valenta R; Eiwegger T; Urbanek R
    Pediatr Allergy Immunol; 2014 Dec; 25(8):788-95. PubMed ID: 25406682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Adjuvants for Enhancing Allergen Immunotherapy Efficacy.
    Chesné J; Schmidt-Weber CB; Esser von-Bieren J
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):125-45. PubMed ID: 26617231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal dendritic cells in allergy and immunotherapy.
    Novak N; Allam JP
    Allergy; 2011 Jul; 66 Suppl 95():22-4. PubMed ID: 21668846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of IL-35 in sublingual allergen immunotherapy.
    Layhadi JA; Eguiluz-Gracia I; Shamji MH
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):12-17. PubMed ID: 30507716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.